Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 2046

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 8
Chunk 2046
---
 

    2025  
    2024 
  
    Cash flows from operating activities: 

    Net loss 
    $(13,388,089) 
    $(12,208,174)
  
    Adjustments to reconcile net loss to net cash used in operating activities: 

    Depreciation and amortization 
     339,559  
     359,057 
  
    Stock-based compensation 
     415,234  
     1,219,370 
  
    Loss on disposal of property, plant and equipment 
     –  
     21,135 
  
    Non-cash lease expense 
     281,208  
     143 
  
    Warrant Inducement Expense 
     4,612,862  
     – 

    Changes in operating assets and liabilities: 

    Prepaid expenses and other current assets 
     113,923  
     (10,232)
  
    Accounts payable and other current liabilities 
     (53,360) 
     156,678 
  
    Due to related parties 
     33,131  
     332,213 
  
    Net cash used in operating activities 
     (7,645,532) 
     (10,129,810)

    Cash flows from investing activities: 

    Purchases of property and equipment 
     –  
     (250,867)
  
    Cash used in investing activities 
     –  
     (250,867)

    Cash flows from financing activities: 

    Tax withholding payments or tax equivalent payments for net share settlement of restricted stock units 
     (18,927) 
     (34,778)
  
    Net proceeds from the issuance of common stock 
     3,539,907  
     1,322,383 
  
    Proceeds from exercise of warrants – standard terms 
     2,054,940  
     – 
  
    Proceeds from exercise of warrants – induced terms 
     2,316,320  
     – 
  
    Commission paid related to warrant inducement 
     (153,979) 
     – 
  
    Legal fees paid related to warrant inducement 
     (10,877) 
     – 
  
    Net cash provided by financing activities 
     7,727,384  
     1,287,